(Q40678569)

22 September 2017

Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'. (English)

1 reference

22 September 2017

0 references

1 reference

4

Wim Van Biesen

1 reference

22 September 2017

Maarten De Wilde

1

1 reference

PubMed ID

27169474

22 September 2017

Marijn Speeckaert

series ordinal

2

1 reference

PubMed ID

27169474

22 September 2017

Rutger Callens

series ordinal

3

1 reference

22 September 2017

12 May 2016

1 reference

22 September 2017

1 reference

22 September 2017

72

1 reference

22 September 2017

2

1 reference

22 September 2017

133-137

1 reference

A Critical Appraisal of “Chronic Lyme Disease”

22 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Prolonged Lyme disease treatment: enough is enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Immune hemolytic anemia associated with drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Biliary complications in the treatment of unsubstantiated Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Hemolytic anemia secondary to mesantoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2016.1180829

10.1080/17843286.2016.1180829

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

27169474